503 related articles for article (PubMed ID: 19734078)
1. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
Horta BA; Sodero AC; de Alencastro RB
J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.
Iyer S; Scotney PD; Nash AD; Ravi Acharya K
J Mol Biol; 2006 May; 359(1):76-85. PubMed ID: 16616187
[TBL] [Abstract][Full Text] [Related]
3. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
4. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.
Davis-Smyth T; Chen H; Park J; Presta LG; Ferrara N
EMBO J; 1996 Sep; 15(18):4919-27. PubMed ID: 8890165
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
Sha D; He YJ
Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
[TBL] [Abstract][Full Text] [Related]
8. Co-localization of vascular endothelial growth factor and its two receptors flt-1 and kdr in the mink placenta.
Winther H; Dantzer V
Placenta; 2001 May; 22(5):457-65. PubMed ID: 11373156
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor and its receptors in the rhesus monkey (Macaca mulatta) endometrium and placenta during early pregnancy.
Wang H; Li Q; Lin H; Yu X; Qian D; Dai J; Duan E; Zhu C
Mol Reprod Dev; 2003 Jun; 65(2):123-31. PubMed ID: 12704722
[TBL] [Abstract][Full Text] [Related]
10. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factor and its receptors, flt-1 and kinase insert domain-containing receptor in normal human endometrium during menstrual cycle].
Wang H; Chen G
Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):729-32. PubMed ID: 12622916
[TBL] [Abstract][Full Text] [Related]
12. VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing.
Santos SC; Miguel C; Domingues I; Calado A; Zhu Z; Wu Y; Dias S
Exp Cell Res; 2007 May; 313(8):1561-74. PubMed ID: 17382929
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
Straume O; Akslen LA
Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor and its receptors in the porcine corpus luteum during the estrous cycle and early pregnancy.
Kaczmarek MM; Kowalczyk AE; Waclawik A; Schams D; Ziecik AJ
Mol Reprod Dev; 2007 Jun; 74(6):730-9. PubMed ID: 17120307
[TBL] [Abstract][Full Text] [Related]
15. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR.
Kendall RL; Wang G; Thomas KA
Biochem Biophys Res Commun; 1996 Sep; 226(2):324-8. PubMed ID: 8806634
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].
Liu JR; Luo SK; Li J; Su C
Ai Zheng; 2007 Jun; 26(6):652-6. PubMed ID: 17562275
[TBL] [Abstract][Full Text] [Related]
17. Comparative integromics on VEGF family members.
Katoh Y; Katoh M
Int J Oncol; 2006 Jun; 28(6):1585-9. PubMed ID: 16685460
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.
Starovasnik MA; Christinger HW; Wiesmann C; Champe MA; de Vos AM; Skelton NJ
J Mol Biol; 1999 Oct; 293(3):531-44. PubMed ID: 10543948
[TBL] [Abstract][Full Text] [Related]
19. VEGF receptor protein-tyrosine kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2008 Oct; 375(3):287-91. PubMed ID: 18680722
[TBL] [Abstract][Full Text] [Related]
20. The expression of vascular endothelial growth factor and its receptors (flt1/fms, flk1/KDR, flt4) and vascular endothelial growth inhibitor in the bovine uterus during the sexual cycle and their correlation with serum sex steroids.
Sağsöz H; Saruhan BG
Theriogenology; 2011 Jun; 75(9):1720-34. PubMed ID: 21396695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
